The CCL2 receptor, CCR2, is present in the Suprachiasmatic nuclei of mice.
Both Ccl2 and Ccr2 shows daily rhythms in expression in SCN tissue.
CCL2 administration to the SCN region can phase-shift the circadian clock.
Ccl2 inhibition ameliorates the circadian outcome of peripheral immune activation.